Surgery
Stratatech Awarded $4.6-Million Clinical Trial Grant for ExpressGraftâ„¢ Antimicrobial Skin Substitute
November 1, 2011 8:46 pm | News | CommentsMADISON, Wis.--(BUSINESS WIRE)--Stratatech Corp., a leader in regenerative medicine, today announced that the company has been awarded a $4.6-million grant by the National Institute of Diabetes and Digestive and Kidney Diseases to support the first human clinical trial of Stratatech's ExpressGraftâ„¢ antimicrobial skin substitute.
ROX Medical Announces First Clinical Use of the ROX FLO2W Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients
November 1, 2011 8:42 pm | News | CommentsSAN CLEMENTE, Calif.--(BUSINESS WIRE)--ROX Medical, Inc., a world leader in the development of unique minimally invasive medical devices for the treatment of advanced COPD and resistant hypertension, today announced the first clinical use of the ROX CO2UPLERTM at the Universitair Ziekenhuis Brussel...
Lighthouse Imaging Announces Patent for Endolume Endoscopic Test Device
October 28, 2011 7:53 am | News | CommentsPORTLAND, MAINE -- Lighthouse Imaging Corporation ( http://www.lighthouseoptics.com ) announces that a key element of its Endolume testing device has been issued Patent #8040496 from the US Patent and Trademark Office. Endolume is a portable handheld device...
Stealth Therapeutics' Invisiportâ„¢ Implantable Arm Port Receives FDA Clearance
October 27, 2011 11:53 am | News | CommentsMADISON, Wis.--(BUSINESS WIRE)--Stealth Therapeutics Inc. announced today that the company has received clearance from the U.S. Food and Drug Administration (FDA) to market its Invisiportâ„¢ product. The Invisiport offers a less invasive, patient-friendly alternative to traditional chest ports...
Covidien Launches World's First Non-Absorbable, Uni-Directional Knotless Suture
October 26, 2011 5:54 am | News | CommentsSAN FRANCISCO--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the first non-absorbable, uni-directional barbed suture, part of its family of V-Locâ„¢ wound closure devices.
Companies & Markets: Global Spinal Surgery Devices Market Forecast to Reach USD 12.6 Billion in 2017
October 25, 2011 11:17 am | News | CommentsLONDON--(BUSINESS WIRE)--Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth. The global market for medical spinal surgery devices is forecast to reach $12.6 billion in 2017 at a CAGR of 10%.
Companies & Markets: China to be the Fastest Growing Endoscopy Devices Market Among Emerging Economies
October 25, 2011 11:02 am | News | CommentsLONDON--(BUSINESS WIRE)--Endoscopy Devices Market in Emerging Economies (India, China, Brazil) - Growing Investments in Hospitals to be the Major Growth Driver. The endoscopy devices market in the emerging economies of China, India and Brazil grew at a Compounded Annual Growth Rate (CAGR) of 4%, 3% and 3%.
Microline Surgical Announces Merger with Starion Instruments
October 25, 2011 10:59 am | News | CommentsBEVERLY, Mass.--(BUSINESS WIRE)--Microline Surgical, a leading manufacturer of reposable instruments for minimally invasive surgery, today announced that it has completed the merger of Starion Instrumentsâ„¢ Corp, a developer of surgical technology for sealing and dividing soft tissue.
'Extreme EVAR and TEVAR' a Hot Topic at the International Symposium on Endovascular Therapy (ISET) 2012
October 25, 2011 7:27 am | News | CommentsMIAMI BEACH, Fla., Oct. 25, 2011 -- Endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) take center stage at the upcoming 24th Annual International Symposium on Endovascular Therapy (ISET), which brings together...
Teleflex Introduces the ArrowADVANTAGE5 â„¢ Pressure-Injectable PICC
October 25, 2011 6:14 am | News | CommentsLIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) today announced the launch of the ArrowADVANTAGE5 pressure-injectable peripherally inserted central catheter (PICC). ArrowADVANTAGE5 provides features clinicians have come to expect in a PICC, plus five unique advantages.
Neurosurgical and Neurovascular Device Market to Grow at Six Percent Per Year
October 25, 2011 6:01 am | News | CommentsTORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016...
Increased Durability, Safety and Effectiveness of Endovascular Prosthesis to Be Main Focus Adopted by Companies
October 24, 2011 11:29 am | by Prasanna Vadhana Kannan | Articles | CommentsEndovascular surgery, a form of minimally invasive surgery, is designed to access regions of the body through the major blood vessels. The basic technique involves the introduction of a catheter percutaneously (or through the skin) into a large blood vessel either through the femoral artery or vein found near the groin. The catheter is injected with a radio-opaque dye that can be seen on an X-ray or fluoroscopy imaging device. As the dye travels through the circulation, the real-time images seen by the radiologists assist in the diagnosis of diseases. Developments of intravascular balloons, stents and coils have allowed new therapies to evolve as alternatives to the traditional open surgeries.
Invuity Introduces Advanced Illuminated Surgical System for Breast Procedures
October 24, 2011 6:44 am | News | CommentsSAN FRANCISCO, Oct. 24, 2011 /PRNewswire/ -- Invuity, a leading developer of state-of-the-art illuminated surgical technology, today introduced its illuminated breast retractor system at the American College of Surgeons' 97th Annual Clinical Congress...
Common Genetic Variants Associated with Development of High-risk Neuroblastoma, Poorer Treatment Outcomes
September 20, 2011 9:41 am | by AACR | News | CommentsTweet • African ancestry linked to increased rates of high-risk disease.• Variants may be found in patients of any ethnic makeup. WASHINGTON, D.C. — Patients with a high degree of African ancestry had a greater incidence of high-risk...
Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results
September 20, 2011 9:40 am | by Bio-Medicine.Org | News | CommentsFARMINGDALE, N.Y., Sept. 20, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and...
AACR Awards 23 Minority Scholar in Cancer Research Awards
September 20, 2011 7:40 am | by AACR | News | CommentsTweet WASHINGTON, D.C. — The American Association for Cancer Research is awarding 23 Minority Scholar in Cancer Research Awards at the Fourth AACR Conference on The Science of Cancer Health Disparities, held Sept. 18-21, 2011, in Washington, D.C. The award, now in its 26th year, is...
FDA Approved, Non-Invasive Laser Is A Success in Trigeminal Neuralgia Pain Treatment
September 19, 2011 11:40 am | by Bio-Medicine.Org | News | CommentsMYRTLE BEACH, S.C., Sept. 19, 2011 /- Laser Med Center , which specializes in treating Trigeminal Neuralgia, has received an FDA approval for its revolutionary laser device. This is a non-invasive alternative to surgery, which treats pain through nerve tissue regeneration. Trigeminal...
Hologic Launches Automated Cervical Cancer Screening Solutions at IPV Meeting in Berlin
September 16, 2011 2:40 pm | by Bio-Medicine.Org | News | CommentsBEDFORD, Mass., Sept. 16, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on two...
Trust Your Derm: The JUVA Skin & Laser Center Advises Patients To Seek Board Certified Dermatologists and AAAHC Accredited Facilities For Safe Cosmetic Procedures
September 16, 2011 2:40 pm | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 16, 2011 /- Choosing the right doctor when opting for cosmetic procedures can be a confusing process. Referrals from peers and subsequent costs often become determining factors rather than the physician's experience and results. Patients need to be educated...
Solos Endoscopy Reports 32% Increase in Breast Endoscopy Sales
September 15, 2011 9:40 am | by Bio-Medicine.Org | News | CommentsBOSTON, Sept. 15, 2011 /- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company has shown a 32% increase in Breast Endoscopy sales for the period of June through August 2011 as compared to the prior year. Management recently reported an increase in demand for...
Portrait Plasma Skin Regeneration Resurfaces at Prestigious Symposium
September 14, 2011 8:40 am | by Bio-Medicine.Org | News | CommentsNYACK, N.Y. and SWANSEA, Wales, Sept. 14, 2011 /- At the historic Grove Park Inn in Asheville, North Carolina, Portrait Plasma Skin Regeneration returned as a technology discussed at the advanced symposium, Controversies & Conversations in Laser and Cosmetic Surgery, directed by Drs....
Thorne Research Launches Thorne Bariatric, an Innovative Nutritional Product Line for Bariatric Surgery Patients
September 14, 2011 8:39 am | by Bio-Medicine.Org | News | CommentsDOVER, Idaho, Sept. 14, 2011 /- Thorne Research, Inc., a leading dietary supplement manufacturer specializing in providing science-based, pure, hypoallergenic nutritional supplements, announced today that it is launching a novel line of dietary supplements – Thorne Bariatric –...
Depuy Spine Announces Global Launch of First Minimally Invasive System for 3D Spine Correction
September 14, 2011 8:39 am | News | CommentsAward-Winning VIPER 3D MIS Correction Set Designed to Treat Complex Pathologies
Pacira Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference
September 13, 2011 4:40 am | by Bio-Medicine.Org | News | CommentsPARSIPPANY, N.J., Sept. 13, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that David Stack, president and chief executive officer of Pacira Pharmaceuticals, is scheduled to present at the UBS Global Life...
Innocoll Announces Top-line Results from its Phase 2 Clinical Trial Investigating XaraColl® for the Management of Post-operative Pain and Receives "Notice of Allowability" fo...
September 13, 2011 4:40 am | by Bio-Medicine.Org | News | CommentsASHBURN, Va., Sept. 13, 2011 /- Innocoll, Inc. announced top-line results from its phase 2 clinical trial investigating XaraColl for the management of post-operative pain and also announced it has received a "Notice of Allowability" for its XaraColl patent application in the United...
